CorriXR Therapeutics
Wilmington
About CorriXR Therapeutics
CorriXR Therapeutics is a biotechnology company. The company is headquartered in Wilmington, Delaware, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2025)
- Website: corrixr.com
- Phone: 302-623-5305
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/corrixr-therapeutics-40300 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.